The global single-use bioprocessing market was valued at USD 27.94 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 16.24% from 2024 to 2030. The adoption of single-use bioprocessing technology is driven by the growing demand for biopharmaceuticals over the past few years, along with an increase in investments for the development of biologics, such as monoclonal antibodies, vaccines, recombinant proteins, and others. Furthermore, benefits pertaining to the use of single-use technology, such as significant reduction in costs and time required for operations & facility construction have supported the implementation of single-use systems in the bioprocessing sector.
The COVID-19 pandemic has generated new growth opportunities for key stakeholders in the industry. Key biopharmaceutical players can leverage the opportunity by expanding their COVID-19-related product offerings by scaling up their production facilities with the implementation of single-use bioprocessing equipment. A significant number of biopharmaceutical companies are actively involved in the development & production of COVID-19 vaccines. These programs are majorly based on single-use technologies as these systems are flexible, cost-effective, and reduce the risk of cross-contamination.
Such an ongoing and continuous increase in the adoption of these bioprocessing systems due to the COVID-19 pandemic is anticipated to drive industry growth. The commercial success of biopharmaceuticals has led single-use manufacturers to expand their production facilities globally. Capacity expansion projects have been a part of many manufacturers’ multi-year plans, to leverage a global reach and a broader customer base. For instance, in December 2020, Merck KGaA invested over USD 42 million to broaden its existing manufacturing facilities in Danvers, Massachusetts, and Jaffrey, New Hampshire, U.S.
This expansion was aimed at enhancing the company’s single-use assembly operations along with other product portfolios. Furthermore, with the rising focus on the development of regenerative medicine, such as cell and gene therapies, increased success of clinical trials, and enhanced rate of regulatory approvals, demand for commercialization of these products is expected to grow in the near future. In addition, owing to the increasing outsourcing activities in biopharmaceutical manufacturing, CMOs are adopting single-use systems for maintaining highly dynamic and frequently changing product portfolios.
Consequently, the extensive implementation of single-use systems in CMOs across the globe is likely to boost industry growth. For instance, in July 2021, Pall Corp. signed a contract with Exothera S.A., a CDMO, to establish a manufacturing space using Allegro STR single-use bioreactors and other technologies. Although innovations in single-use technology are the current trend for the bioprocessing industry, the technology has still not completely displaced stainless steel reusable systems. High-volume biopharmaceutical product manufacturers continue to fixate on the multi-use system due to their feasibility at large scales. This represents a significant challenge for the industry's growth.
Market growth for the single-use bioprocessing market is high and market growth is accelerating. Innovation of technologically advanced products is one of the major driving factors of the market. In August 2023, Trelleborg Healthcare and Medicallaunched the BioPharmaPro family of advanced products and services for fluid path single-use equipment to bolster the development of advanced therapies.
The market is also characterized by a high level of merger and acquisition (M&A) activity by the leading players. For instance, In March 2023, Thermo Fisher Scientific announced an update to the strategic collaboration with Arsenal Biosciences for the creation of manufacturing processes for advanced cancer treatments. This research-oriented collaboration has enabled ArsenalBio to create an efficient manufacturing process for the next-gen, autologous programmable T cells for the treatment of cancer
Companies operating in the bioprocessing space can obtain legal protection for innovative technologies and processes through patents, trademarks, etc. Licensing and collaborative agreements for increasing product distribution represent opportunities for market expansion. However, regulatory authorities are focusing on establishing stringent guidelines for biosafety, quality control, and other factors. Hence, compliance with regulatory standards represents significant challenges for market growth.
Currently, North America and Europe are the leading regions in the SU bioprocessing space. Key companies operating in the market are largely focusing on expanding into these lucrative regions to capture a greater share of the market. For instance, in May 2022, Cytiva opened a new manufacturing facility in Switzerland. The facility will focus on manufacturing single-use kits and consumables
The simple & peripheral elements segment recorded the largest market share of 49.31% in 2023 due to continuous innovations in these products and increasing prominence of bioprocessing operations in overall manufacturing process. Tubing, filters, connectors, and transfer systems held a majority share within simple & peripheral elements as tubing and connectors are provided by most single-use suppliers in a compatible format with single-use bags, bioreactors, or other single-use bioprocessing apparatus. For instance, Thermo Fisher Scientific, Inc. offers customization options to add tubing and connectors to its bioprocessing container bags and other bioprocessing equipment.These factors are expected to drive the segment.
The apparatus & plants segment is projected to grow at a rapid CAGR over the forecast period due to its significant penetration in the bioprocessing space majorly driven by a variety of single-use bioreactors. For instance, single-use bioreactors are available from a working volume range of 15 mL and 250 mL, such as the Ambr 15 and 250 sold by Sartorius AG, to a working volume of 6000 L, such as the CSR 7500 SUB sold by ABEC. This allows the end-users to easily scale products right from the stage of clone selection and benchtop production to harvesting high-volume yields of biologics. As a result, the availability of a broad range of options for apparatus & plants for bioprocessing is anticipated to drive the segment.
The upstream bioprocessing segment held the largest market share in 2023. This can be attributed to the continuous developments and advancements in technologies for upstream bioprocessing. For instance, advanced products, such as Ambr 15 micro-bioreactor system by Sartorius AG, are offering high-throughput upstream process development as well as efficient cell culture processing and media & feed optimization with automated experimental setup and sampling. These solutions can reduce the time taken for upstream bioprocessing operations and are anticipated to boost segment growth.
The fermentation segment is expected to register significant CAGR over the forecast period. The growth can be attributed to the launch of several innovative fermentation offerings that provide optimum conditions for bioprocessing reactions. For instance, the HyPerforma Enhanced S.U.F by Thermo Fisher Scientific, Inc. delivers optimal oxygen mass transfers and temperature control to the culture by increasing the turbine impellers and cooling jacket surface areas, respectively. Furthermore, companies like Cytiva are also involved in bringing single-use fermentation solutions for their end-users, such as the Xcellerex XDR MO, a stirred tank system with powerful mixing, efficient temperature control, and high oxygen transfer capacities for microbial cell culture. Significant innovations like these are likely to aid in revenue generation in this segment.
Biopharmaceutical manufacturers dominated the market and accounted for the highest share in 2023. An increase in the commercial success of biologics in recent years and a rise in contract manufacturing/research services have led to the high growth of the segment. CROs and CMOs can offer several benefits in bioprocessing operations, such as scalability, flexibility, decreased internal infrastructure requirements, and dedicated supply channels. These advantages are fueling the adoption of contract services and are anticipated to positively affect the industry growth in the near future.
Academic & clinical research institutes are expected to grow at the fastest CAGR during 2024-2030.The availability of benchtop scale bioprocessing equipment and technological progress in single-use systems has accelerated the adoption of such technologies in academic and research institutes. For instance, institutes like the NIBRT (National Institute for Bioprocessing Research), in Ireland offer contract research services for biologics, while also conducting workshops and training for single-use technologies. Furthermore, the involvement of academic institutes and scientific communities in developing new biologics, such as cell & gene therapies and vector production, is likely to increase the implementation of single-use systems due to its cost reduction and flexibility benefits.
North America held the largest revenue share of more than 34.19% in 2023, which can be attributed to the presence of an established pharmaceutical and biomanufacturing industry in the region as well as a high extent of R&D activities. Similarly, the demand for single-use bioprocessing equipment is also driven by an increasing focus on vaccine production to aid in disease prevention measures in the region. Moreover, the presence of the Bio-process System Alliance (BPSA) in North America, which aims at advancing the adoption of single-use technologies, is expected to further drive the sales of disposable systems in the region.
The Asia Pacific region is expected to grow at the fastest rate over the forecast period. The region’s growing bioprocessing market has resulted in multiple investments from several global companies. These investments assist in serving the key companies to create a regional presence and take advantage of the untapped avenues. Furthermore, the increasing interest of contract service providers to develop their base in the Asia Pacific, coupled with the trend of implementation of disposables in CMOs, acts as a catalyst for continued investments by local as well as global companies. For instance, in September 2021, Singapore witnessed the expansion of Lonza’s drug development facility. The CDMO enhanced its capacity to support the growing manufacturing needs in the region.
In China, the expansion of biopharmaceuticals market is driving the single-use bioprocessing market. Several international companies have expanded their manufacturing footprint in this region by forming mutually beneficial partnerships with China-based entities. Moreover, the primary focus of the country is on the development of affordable biosimilars of Western novel biotherapeutics for its domestic market, which is anticipated to positively influence market growth in the coming years.
The market is witnessing several strategic initiatives such as product launches, expansions adopted by key players to increase their reach in the market and to maintain their industry presence. These developments also enhance the availability of their products in diverse geographical areas.
The following are the leading companies in the single-use bioprocessing market. These companies collectively hold the largest market share and dictate industry trends. Financials, strategy maps & products of these single-use bioprocessing companies are analyzed to map the supply network.
In January 2024, CDMO AGC Biologics announced a growth strategy to develop pharmaceutical manufacturing capabilities in the Asia region through the expansion of their mammalian cell culture, mRNA and cell therapy facility in Japan. This development is aimed to support the global demand for biologics and advanced therapy medicinal products.
In September 2023, Getinge launched a single-use bioreactor named the AppliFlex ST GMP. The new product is available in different sizes and provides a comprehensive cGMP manufacturing solution for mRNA production and cell and gene therapies.
In April 2023, Merck KGaA launched Ultimus, a single-use process container film, to provide superior strength & leak resistance for single-use assemblies.
In April 2023, Cytiva introduced the X-platform bioreactors that simplifies the upstream bioprocessing operations for the production of monoclonal antibodies (mAbs), protein-based drugs and cell and gene therapies.
Report Attribute |
Details |
Market size value in 2024 |
USD 33.11 billion |
Revenue forecast in 2030 |
USD 80.13 billion |
Growth rate |
CAGR of 16.24% from 2024 to 2030 |
Actual data |
2018 - 2023 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, workflow, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; South Korea; Australia; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
Key companies profiled |
Sartorius AG; Danaher Corporation; Thermo Fisher Scientific, Inc.; Merck KGaA; Avantor, Inc; Eppendorf SE; Corning Incorporated; Lonza; PBS Biotech, Inc.; Meissner Filtration Products, Inc. |
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2018 to 2030. For the purpose of this report, Grand View Research has segmented the single-use bioprocessing market on the basis of product, workflow, end-use, and regions:
By Product Outlook (Revenue, USD Million, 2018 - 2030)
Simple & Peripheral Elements
Tubing, Filters, Connectors, & Transfer Systems
Bags
Sampling Systems
Probes & Sensors
pH Sensor
Oxygen Sensor
Pressure Sensors
Temperature Sensors
Conductivity Sensors
Flow Sensors
Others
Others
Apparatus & Plants
Bioreactors
Upto 1000L
Above 1000L to 2000L
Above 2000L
Mixing, Storage, & Filling Systems
Filtration System
Chromatography Systems
Pumps
Others
Work Equipment
Cell Culture System
Syringes
Others
By Workflow Outlook (Revenue, USD Million, 2018 - 2030)
Upstream Bioprocessing
Fermentation
Downstream Bioprocessing
By End-use Outlook (Revenue, USD Million, 2018 - 2030)
Biopharmaceutical Manufacturers
CMOs & CROs
In-house Manufacturers
Academic & Clinical Research Institutes
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
South Korea
Australia
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
b. The global single-use bioprocessing market size was estimated at USD 23,433.3 million in 2022 and is expected to reach USD 27,944.2 million in 2023.
b. The global single-use bioprocessing market is expected to witness a compound annual growth rate of 16.24% from 2023 to 2030 to reach USD 80,129 million by 2030.
b. The simple and peripheral elements segment, which includes filters, tubing, transfer systems, and connectors, dominated the market for single-use bioprocessing and accounted for the largest revenue share of 49.10% in 2022.
b. Some key participants in the market for single-use bioprocessing include Sartorius AG; Eppendorf AG; General Electric Company (GE Healthcare); Corning Incorporated; ThermoFisher Scientific; Rentschler Biopharma SE; Merck KGaA; and Pall Corporation.
b. Commercial advantages of single-use technology within the bioprocessing industry with respect to operating & production costs, and new product development timelines, have driven the revenue of the single-use bioprocessing market.
b. The upstream workflow segment dominated the single-use bioprocessing market and accounted for the largest revenue share of 57.86% in 2022.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Product Segment
1.1.2. Workflow Segment
1.1.3. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Primary Research
1.6. Information or Data Analysis:
1.6.1. Data Analysis Models
1.7. Market Formulation & Validation
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. List of Abbreviations
1.11. Objective
1.11.1. Objective 1
1.11.2. Objective2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Several advantages associated with implementation of single use technology in bio-manufacturing process
3.2.1.2. Increasing investments in expansion of cGMP manufacturing
3.2.1.3. Widespread adoption of single use technology by CMOs
3.2.2. Market Restraint Analysis
3.2.2.1. Concerns due to leachable and extractable
3.2.2.2. Limited adoption of single use technology in downstream process
3.2.3. Market Challenge Analysis
3.2.3.1. Delay in the delivery speed and supply chain of customized products
3.2.3.2. Restraints with scalability of single-use operations
3.2.3.3. Vast availability of multi-use systems
3.2.4. Market Opportunity Analysis
3.2.4.1. Developing technologies for downstream adoption
3.2.4.2. CMO-outsourcing to focus on the new product development
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
3.3.4. Average Pricing Analysis
Chapter 4. Product Business Analysis
4.1. Single-use Bioprocessing Market: Product Movement Analysis
4.2. Simple & Peripheral Elements
4.2.1. Simple & peripheral elements market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.2. Tubing, Filters, Connectors, & Transfer Systems
4.2.2.1. Tubing, Filters, Connectors, & Transfer Systems market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.3. Bags
4.2.3.1. Bags market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.4. Sampling Systems
4.2.4.1. Sampling systems market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.5. Probes & Sensors
4.2.5.1. Probes & sensors market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.5.2. pH Sensor
4.2.5.2.1. pH sensor market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.5.3. Oxygen Sensor
4.2.5.3.1. Oxygen sensor market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.5.4. Pressure Sensors
4.2.5.4.1. Pressure sensors market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.5.5. Temperature Sensors
4.2.5.5.1. Temperature sensors market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.5.6. Conductivity Sensor
4.2.5.6.1. Conductivity sensor market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.5.7. Flow Sensors
4.2.5.7.1. Flow sensors market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.5.8. Others
4.2.5.8.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.6. Others
4.2.6.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
4.3. Apparatus & Plants
4.3.1. Apparatus & plants market estimates and forecasts, 2018 - 2030 (USD Million)
4.3.2. Bioreactors
4.3.2.1. Bioreactors market estimates and forecasts, 2018 - 2030 (USD Million)
4.3.2.2. Upto 1000L
4.3.2.2.1. Upto 1000L market estimates and forecasts, 2018 - 2030 (USD Million)
4.3.2.3. Above 1000L to 2000L
4.3.2.3.1. Above 1000L to 2000L market estimates and forecasts, 2018 - 2030 (USD Million)
4.3.2.4. Above 2000L
4.3.2.4.1. Above 2000L market estimates and forecasts, 2018 - 2030 (USD Million)
4.3.3. Mixing, Storage, & Filling Systems
4.3.3.1. Mixing, storage, & filling systems market estimates and forecasts, 2018 - 2030 (USD Million)
4.3.4. Filtration System
4.3.4.1. Filtration system market estimates and forecasts, 2018 - 2030 (USD Million)
4.3.5. Chromatography Systems
4.3.5.1. Chromatography systems market estimates and forecasts, 2018 - 2030 (USD Million)
4.3.6. Pumps
4.3.6.1. Pumps market estimates and forecasts, 2018 - 2030 (USD Million)
4.3.7. Others
4.3.7.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
4.4. Work Equipment
4.4.1. Work equipment market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.2. Cell Culture System
4.4.2.1. Cell culture system market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.3. Syringes
4.4.3.1. Syringes market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.4. Others
4.4.4.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. Workflow Business Analysis
5.1. Single-use Bioprocessing Market: Workflow Movement Analysis
5.2. Upstream Bioprocessing
5.2.1. Upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
5.3. Fermentation
5.3.1. Fermentation market estimates and forecasts, 2018 - 2030 (USD Million)
5.4. Downstream Bioprocessing
5.4.1. Downstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. End Use Business Analysis
6.1. Single-use Bioprocessing Market: End Use Movement Analysis
6.2. Biopharmaceutical Manufacturers
6.2.1. Biopharmaceutical manufacturers market estimates and forecasts, 2018 - 2030 (USD Million)
6.2.2. CMOs & CROs
6.2.2.1. CMOs & CROs market estimates and forecasts, 2018 - 2030 (USD Million)
6.2.3. In-house Manufacturers
6.2.3.1. In-house manufacturers market estimates and forecasts, 2018 - 2030 (USD Million)
6.3. Academic & Clinical Research Institutes
6.3.1. Academic & clinical research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Single-use Bioprocessing Share By Region, 2023 & 2030
7.2. North America
7.2.1. North America Single-use Bioprocessing, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. U.S. Single-use Bioprocessing, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Canada Single-use Bioprocessing, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Single-use Bioprocessing, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. UK Single-use Bioprocessing, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Germany Single-use Bioprocessing, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. France Single-use Bioprocessing, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Italy Single-use Bioprocessing, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Spain Single-use Bioprocessing, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Denmark Single-use Bioprocessing, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Sweden Single-use Bioprocessing, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Norway Single-use Bioprocessing, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Single-use Bioprocessing, 2018 - 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Japan Single-use Bioprocessing, 2018 - 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. China Single-use Bioprocessing, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. India Single-use Bioprocessing, 2018 - 2030 (USD Million)
7.4.5. Australia
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Australia Single-use Bioprocessing, 2018 - 2030 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Thailand Single-use Bioprocessing, 2018 - 2030 (USD Million)
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. South Korea Single-use Bioprocessing, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Single-use Bioprocessing, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Brazil Single-use Bioprocessing, 2018 - 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Mexico Single-use Bioprocessing, 2018 - 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Argentina Single-use Bioprocessing, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. MEA Single-use Bioprocessing, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. South Africa Single-use Bioprocessing, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Saudi Arabia Single-use Bioprocessing, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. UAE Single-use Bioprocessing, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Kuwait Single-use Bioprocessing, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Company Profiles/Listing
8.4.1. Sartorius AG
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Thermo Fisher Scientific, Inc.
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Danaher
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Merck KGaA
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Avantor Inc.
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Eppendorf SE
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Corning Incorporated
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Meissner Filtration Products, Inc.
8.4.8.1. Overview
8.4.8.2. Product Benchmarking
8.4.8.3. Strategic Initiatives
8.4.9. Lonza
8.4.9.1. Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. PBS Biotech, Inc.
8.4.10.1. Overview
8.4.10.2. Product Benchmarking
8.4.10.3. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 4 Global single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 5 Global single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 6 Global single-use bioprocessing market, by region, 2018 - 2030 (USD Million)
Table 7 North America single-use bioprocessing market, by country, 2018 - 2030 (USD Million)
Table 8 North America single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 9 North America single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 10 North America single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 11 U.S. single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 12 U.S. single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 13 U.S. single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 14 Canada single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 15 Canada single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 16 Canada single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 17 Europe single-use bioprocessing market, by country, 2018 - 2030 (USD Million)
Table 18 Europe single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 19 Europe single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 20 Europe single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 21 Germany single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 22 Germany single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 23 Germany single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 24 UK single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 25 UK single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 26 UK single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 27 France single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 28 France single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 29 France single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 30 Italy single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 31 Italy single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 32 Italy single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 33 Spain single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 34 Spain single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 35 Spain single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 36 Denmark single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 37 Denmark single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 38 Denmark single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 39 Sweden single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 40 Sweden single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 41 Sweden single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 42 Norway single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 43 Norway single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 44 Norway single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 45 Asia Pacific single-use bioprocessing market, by country, 2018 - 2030 (USD Million)
Table 46 Asia Pacific single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 47 Asia Pacific single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 48 Asia Pacific single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 49 China single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 50 China single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 51 China single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 52 Japan single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 53 Japan single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 54 Japan single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 55 India single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 56 India single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 57 India single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 58 South Korea single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 59 South Korea single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 60 South Korea single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 61 Australia single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 62 Australia single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 63 Australia single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 64 Thailand single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 65 Thailand single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 66 Thailand single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 67 Latin America single-use bioprocessing market, by country, 2018 - 2030 (USD Million)
Table 68 Latin America single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 69 Latin America single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 70 Latin America single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 71 Brazil single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 72 Brazil single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 73 Brazil single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 74 Mexico single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 75 Mexico single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 76 Mexico single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 77 Argentina single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 78 Argentina single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 79 Argentina single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa single-use bioprocessing market, by country, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 83 Middle East & Africa single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 84 South Africa single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 85 South Africa single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 86 South Africa single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 89 Saudi Arabia single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 90 UAE single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 91 UAE single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 92 UAE single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 93 Kuwait single-use bioprocessing market, by product, 2018 - 2030 (USD Million)
Table 94 Kuwait single-use bioprocessing market, by workflow, 2018 - 2030 (USD Million)
Table 95 Kuwait single-use bioprocessing market, by end-use, 2018 - 2030 (USD Million)
Table 96 Participant’s overview
Table 97 Financial performance
Table 98 Key companies undergoing expansions
Table 99 Key companies undertaking acquisitions
Table 100 Key companies undergoing collaborations
Table 101 Key companies launching new products/services
Table 102 Key companies undergoing partnerships
Table 103 Key companies undertaking other strategies
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market summary, 2023 (USD Million)
Fig. 9 Market segmentation & scope
Fig. 10 Types of bioprocessing systems
Fig. 11 Market trends and outlook
Fig. 12 Market driver impact
Fig. 13 Market restraint impact
Fig. 15 Porter’s analysis
Fig. 16 SWOT analysis
Fig. 17 Single-use bioprocessing market: Product outlook and key takeaways
Fig. 18 Single-use bioprocessing market: Product movement analysis
Fig. 19 Global simple and peripheral elements market, 2018 - 2030 (USD Million)
Fig. 20 Global tubing, filters, connectors and transfer systems market, 2018 - 2030 (USD Million)
Fig. 21 Global single-use bags market, 2018 - 2030 (USD Million)
Fig. 22 Global single-use sampling systems market, 2018 - 2030 (USD Million)
Fig. 23 Global single-use probes and sensors market, 2018 - 2030 (USD Million)
Fig. 24 Global single-use pH sensors market, 2018 - 2030 (USD Million)
Fig. 25 Global single-use oxygen sensors market, 2018 - 2030 (USD Million)
Fig. 26 Global single-use pressure sensors market, 2018 - 2030 (USD Million)
Fig. 27 Global single-use temperature sensors market, 2018 - 2030 (USD Million)
Fig. 28 Global single-use conductivity sensors market, 2018 - 2030 (USD Million)
Fig. 29 Global single-use flow sensors market, 2018 - 2030 (USD Million)
Fig. 30 Global single-use other sensors market, 2018 - 2030 (USD Million)
Fig. 31 Global single-use other single and peripheral elements market, 2018 - 2030 (USD Million)
Fig. 32 Global single-use apparatus and plants market, 2018 - 2030 (USD Million)
Fig. 33 Global single-use bioreactors market, 2018 - 2030 (USD Million)
Fig. 34 Global single-use bioreactors with capacity up to 1000L market, 2018 - 2030 (USD Million)
Fig. 35 Global single-use bioreactors with capacity above 1000L to 2000L market, 2018 - 2030 (USD Million)
Fig. 36 Global single-use bioreactors with capacity above 2000L market, 2018 - 2030 (USD Million)
Fig. 37 Global mixing, storage and filling systems market, 2018 - 2030 (USD Million)
Fig. 38 Global single-use filtration systems market, 2018 - 2030 (USD Million)
Fig. 39 Global single-use chromatography systems market, 2018 - 2030 (USD Million)
Fig. 40 Global single-use pumps market, 2018 - 2030 (USD Million)
Fig. 41 Global single-use other apparatus and plants market, 2018 - 2030 (USD Million)
Fig. 42 Global single-use work equipment market, 2018 - 2030 (USD Million)
Fig. 43 Global single-use cell culture system market, 2018 - 2030 (USD Million)
Fig. 44 Global single-use syringes market, 2018 - 2030 (USD Million)
Fig. 45 Global single-use other work equipment market, 2018 - 2030 (USD Million)
Fig. 46 Single-use bioprocessing market: Workflow outlook and key takeaways
Fig. 47 Single-use bioprocessing market: Workflow movement analysis
Fig. 48 Global single-use upstream bioprocessing market, 2018 - 2030 (USD Million)
Fig. 49 Global single-use fermentation bioprocessing market, 2018 - 2030 (USD Million)
Fig. 50 Global single-use downstream bioprocessing market, 2018 - 2030 (USD Million)
Fig. 51 Single-use bioprocessing market: End-use outlook and key takeaways
Fig. 52 Single-use bioprocessing market: End-use movement analysis
Fig. 53 Global single-use bioprocessing market for biopharmaceutical manufacturers, 2018 - 2030 (USD Million)
Fig. 54 Global single-use bioprocessing market for in-house biopharmaceutical manufacturers, 2018 - 2030 (USD Million)
Fig. 55 Global single-use bioprocessing market for CMOs and CROs, 2018 - 2030 (USD Million)
Fig. 56 Global single-use bioprocessing market for academic and clinical research institutes, 2018 - 2030 (USD Million)
Fig. 57 Single-use bioprocessing market: Regional outlook and key takeaways
Fig. 58 Single-use bioprocessing market: Regional movement analysis
Fig. 59 North America single-use bioprocessing market, 2018 - 2030 (USD Million)
Fig. 60 U.S. single-use bioprocessing market, 2018 - 2030 (USD Million)
Fig. 61 Canada single-use bioprocessing market, 2018 - 2030 (USD Million)
Fig. 62 Europe single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 Germany single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 France single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 UK single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 Italy single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 Spain single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 Denmark single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 69 Sweden single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 Norway single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 Rest of Europe single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Asia-Pacific single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73 China single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 India single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 South Korea single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Japan single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 77 Australia single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Thailand single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 79 Rest of APAC single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Latin America single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 81 Brazil single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 82 Mexico single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 83 Argentina single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 84 Rest of LATAM single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 85 MEA single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 86 South Africa single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 87 Saudi Arabia single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 88 UAE single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 89 Kuwait single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 90 Rest of MEA single-use bioprocessing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 91 Strategy framework
Fig. 92 Participant categorization
Market Segmentation
Single-use technology has been introduced in the market since several years, but with the surging requirement of biopharmaceuticals for the past couple years, implementation of single-use system in the bioprocessing market has also boosted. With key pharmaceutical players making huge investments in their biotechnology portfolio, the global market for biologics such as recombinant protein, MAbs, vaccines, and cell and gene therapy is extending each year. Advantages relating to the usage of single-use technology (SUT), such as substantial cost reduction in capital, reduced time in operation and construction of a facility and environment sustainability have sustained the implementation of single-use systems in the bioprocessing market. The present industry trend of perfusion and incessant cell culture in bioprocessing has empowered the usage of single-use equipment on a huge scale. Single-use technologies provide improved mobility, easy sampling, increased productivity, and paced product changeovers, which in turn have enhanced their implementation in the biopharmaceutical sector. Technological progressions in single-use systems have resulted in automation and in an easy to use equipment that has decreased labor intensive procedures. Moreover, total exclusion of clean in place (CIP) and sterilize in place (SIP) has diminished product carryover and the hazard of cross- contamination owing to inadequate cleaning.
The commercial success of biopharmaceuticals and its following demand will need several production facilities to fulfil the demand for bioprocessing in the market. Biopharmaceutical producers are incorporating single-use facilities for faster product turnaround time and to house numerous product manufacturing processes in the same production space. The surging demand for single-use application in the biopharmaceutical market has resulted in single-use manufacturers to enlarge their single-use production facilities across the world. Capacity expansion projects have been part of various manufacturers’ multi-year plan, to control a global reach and a broader customer base. Furthermore, global dominance of manufacturers reduces the cost of shipment and lastly results in reduced capital expenditures. For example, Merck, in December 2020, made an announcement regarding the expansion of capacities of its previously existing industrial facilities in Danvers, Massachusetts, and Jaffrey, New Hampshire, U.S. with USD 42 million investment. This expansion was intended for single-use assembly operations along with other product portfolios. Moreover, strategic initiatives such as mergers and acquisitions also results in growth of the manufacturing facilities across the globe.
Concerns regarding to potential leachable and extractable materials is predicted to hinder the growth of this market. Product streams in downstream processing are measured as clean and there may not be further processing, which will aid in clearing anything that is presented into process stream by disposables. Therefore, concerns associated with extractables and leachables are one of the prime issues detected and mentioned by single use biomanufacturers. However, initiatives are being undertaken for addressing the problems regarding extractables and leachables. Numerous meetings have been held between companies operating in biopharmaceutical sector and regulators for standardization of extractables and leachables testing and risk assessment approaches.
This section will provide insights into the contents included in this single-use bioprocessing market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.
Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
Company overview
Financial performance
Product benchmarking
Latest strategic developments
Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance
A three-pronged approach was followed for deducing the single-use bioprocessing market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:
Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for single-use bioprocessing market to gather the most reliable and current information possible.
Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of single-use bioprocessing market data depending on the type of information we’re trying to uncover in our research.
Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.
Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.
Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.
Qualitative Functional Deployment (QFD) Modelling for market share assessment.
Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.
Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.
Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.
This step also entails the finalization of the report scope and data representation pattern.
Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.
The single-use bioprocessing market was categorized into four segments, namely product (Simple & Peripheral Elements, Apparatus & Plants, Work Equipment), workflow (Upstream Bioprocessing, Fermentation, Downstream Bioprocessing), end-use (Biopharmaceutical Manufacturers, Academic & Clinical Research Institutes), regions (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).
The single-use bioprocessing market was segmented into product, workflow, end-use, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:
Demand estimation of each product across countries/regions summed up to from the total market.
Variable analysis for demand forecast.
Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.
Primary interviews for data revalidation and insight collection.
Used extensively for new product forecasting or analyzing penetration levels.
Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.
Primary interviews and vendor-based primary research for variable impact analysis.
The single-use bioprocessing market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, Middle East and Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; the UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; South Korea; Australia; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait.
All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.
The single-use bioprocessing market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:
Sartorius AG - Sartorius AG provides services associated with pharmaceutical products and laboratory equipment. Sartorius Group functions under Sartorius AG. Its business is segmented into two divisions: bioprocess solutions and lab products & services. Its bioprocess solutions business provides products for process control, fluid management, media & buffers, bioreactors & fermentors, and configural single-use system. Through its lab products & services business, it presents products for weighing, liquid handling filtration/purification, lab water purification, quality control, and cell cultivation. This company was established by Florenz Sartorius and its subsidiaries are situated in approximately 30 nations.
Danaher - Danaher’s diagnostic and life sciences business functions collectively to provide products and solutions for both disease treatment and life sciences research. Danaher’s life science companies are engaged in creating products for clinical research facilities, government agencies, and academic establishments. It provides filtration, separation, and purification technologies for the biopharmaceutical industry. In August 2015, Danaher concluded the acquisition of Pall Corporation to boost its life sciences business segment. Danaher corporation is situated in Washington D.C., U.S. and was founded in the year 1969. The company has a strength of 80,000+ employees with more than 20 operating subsidiaries and located in more than 60 countries. The company has three business segments: diagnostics, life sciences, environmental, and applied solutions.
Pall Corporation - Pall Corporation runs as a subsidiary of Danaher post its acquisition in August 2015. It is involved in designing and selling of products and solutions for purification, separation, and filtration processes. It provides solutions for entities involved in the development of biotech drugs, cell therapies, vaccines, and classic pharmaceuticals. It has global operations in the Americas, Europe & Middle East Africa, and Asia Pacific.
Cytiva - Cytiva is headquartered in Massachusetts, U.S. with a strength of 7000 associates across 40 countries and was founded in 1968. Danaher acquired the biopharma business of General Electric Company’s Life science division. In March 2020, this acquisition resulted in the establishment of Cytiva, a standalone operating company within the Danaher Life sciences segment. Cytiva provides solutions in cell culture, chromatography, drug product filing, and SUT.
Thermo Fisher Scientific, Inc. - Thermo Fisher Scientific, Inc. is a publicly held biotechnology company, established after a collaboration between Fisher Scientific and Thermo Electron. Thermo Fisher provides products in life sciences, industrial & applied sciences, and clinical diagnostics. The company has operations in over 50 countries. The Life Technologies Corporation operates as a subsidiary of Thermo Fisher since April 2013. Thermo Fisher Scientific, Inc. attained a large market share in the single-use bioprocessing space via the acquisition of Advanced Scientific and Finesse Solutions in 2015 and 2017, respectively. Patheon and PPD acquired by Thermo Fisher Scientific, Inc. in 2017 and 2021 also expands the company’s portfolio of industry level CDMO and clinical research services. It acquired Affymetrix, Inc. in March 2016. The company offers services via different brands, namely; Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and Pharmaceutical Product Development (PPD).
Merck KGaA - Founded in the year 1668 in Darmstadt, Germany with a work force of more than 60,000 employees, the Merck Group is public held company. The Merck group is known as EMD in the U.S. and Canada due to legal reasons. The company segments its market in life science, healthcare and electronics. It has worldwide operations in North America, Europe, Asia, Latin America, Oceania, and Africa. It offers solutions via its different brands, namely Millipore, Sigma Aldrich, BioReliance, SAFC, Milli-Q, Supelco. The life science business segment of the company operates as MilliporeSigma, which is a combination of the Millipore Corporation and Sigma Aldrich acquired in 2010 and 2015, respectively. The BioReliance brand offers the pharma and biopharma manufacturing and testing solutions as a CDMO.
Millipore sigma - As part of the Merck Group, Milipore sigma offers portfolio of preparation, separation, filtration and monitoring products. The Millipore portfolio is an ecosystem of products that are endlessly developing to offer smart and easy for usage product range in cell culture systems Single and multi-use systems, filtration and concentrations, purification and separation, and detection and monitoring.
Avantor, Inc. - Avantor is a publicly held company established in 1904 with headquarters at Pennsylvania, U.S. The company serves in four markets: biopharma, healthcare, advanced technologies & applied materials, education & government. These businesses are provided across three major geographic regions; Europe, Americas, and AMEA with a workforce of 13,500 employees across 30 different nations. Avantor is one of the key market leading provider of critical service and products to its customers in the aforementioned four markets. The worlwide customers of Avantor are served through the flagship brands; NuSil, J.T. Baker, Macron Fine Chemicals, Purltan Products, BeneSphera, Rankem, Avantor by VWR and Poch. The company’s product portfolio is vast and is employed across various stages of research, development and production.
VWR International LLC - Avantor successfully completed the acquisitions of VWR International, LLC in November 2017 and since then VWR operates as a wholly-owned subsidiary of Avantor. VWR International, LLC is a U.S.-based company founded in 1852 that is engaged in the marketing and distribution of research laboratory solutions. VWR’s established supply channel and multiple customer relationships added an advantage to the operations of Avantor. Companies acquired by VWR are currently a part of Avantor. JM Separations, STI Components LLC, PAW BioScience Products, LLC, and Integra Companies, LLC were acquired by VWR and are now consolidated under one legal company- Avantor Fluid Handling, LLC. JM Separations was established in 1995 in the U.S. and offers single-use bags, tank liners, and other solutions used for fluid handling The company is engaged in designing and manufacturing single-use equipment for both upstream and downstream processing. It offers single-use solutions for media/buffer preparation, cell recovery, concentration, and diafiltration & chromatographic processes in all mAbs, vaccine, and pharmaceutical proteins.
Eppendorf SE - Eppendorf SE is a life sciences company that produces and presents services, instruments, and consumables for sample handling, cell handling, and liquid handling in laboratories. Its product portfolio involves ultra-low temperature freezers, mixers, dispensers, shakers, fermenters, spectrometers, DNA amplification equipment, centrifuges, pipettes & automated pipetting systems, bioreactors, CO2 incubators, and cell manipulation systems. The company provides products for next-generation sequencing, genome editing, cell biology, molecular biology, microbiology, bioprocessing R&D, stem cells, biofuels, verification of foreign DNA, antibody production, bioprocessing food, environmental aspects, biochemistry, and forensic DNA typing.
Supply Side Estimates
Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.
Segment revenue determination via variable analysis and penetration modeling.
Competitive benchmarking to identify market leaders and their collective revenue shares.
Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.
Demand side estimates
Identifying parent markets and ancillary markets
Segment penetration analysis to obtain pertinent
revenue/volume
Heuristic forecasting with the help of subject matter experts
Forecasting via variable analysis
Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.
Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.
Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.
The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.
The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.
We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.
All market estimates and forecasts have been validated through primary interviews with the key industry participants.
Inflation has not been accounted for to estimate and forecast the market.
Numbers may not add up due to rounding off.
Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).
Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).
Latin America includes Central American countries and the South American continent
Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.
GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.
We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:
Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.
Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.
The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."